Shinpoong Pharmaceutical stock price

신풍제약KRX:019170 · KOSPI · Healthcare · sector #23
₩9,790-11.08%
2026-10-08 close
Loading chart…

Shinpoong Pharmaceutical's chart data is dated 2026-10-08. Recorded technical signals: MACD bullish cross. There are 0 published signal records.

Shinpoong Pharmaceutical last closed at ₩9,790 (-11.08%) on 2026-10-08. Signals today: MACD bullish cross. Listed on KOSPI. Trailing 12 months PER is -620.3×. Its overall grade ranks 153 of 308 stocks in Healthcare.

About this company

Shinpoong Pharmaceutical last closed at ₩9,790 (-11.08%) on 2026-10-08. Signals today: MACD bullish cross. Listed on KOSPI.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall B · 153/308

Valuation grade A

Details →

Recent filings

DART · received recent list, not a complete filing history. Factual information, not investment advice.

Details →

Related stocks

  • 셀트리온Competitor

    제약/바이오 항감염제·의약품 시장에서 국내 경쟁사

  • 유한양행Competitor

    전문의약품 중심의 국내 대형 제약사 경쟁사

  • 종근당Competitor

    국내 처방의약품 시장에서 경쟁하는 주요 제약사

Details →
About Shinpoong Pharmaceutical
What technical signals does Shinpoong Pharmaceutical (019170) have?
Shinpoong Pharmaceutical current technical signals: MACD bullish cross.
Is Shinpoong Pharmaceutical a cup-and-handle pattern?
No. Shinpoong Pharmaceutical has no valid Cup signal right now.
What published figures are available for Shinpoong Pharmaceutical?
Market cap: KRW 554.45B. Trailing 12 months PER: -620.3×. Latest quarter PBR: 1.82×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-09 dataset

Turn what you saw on this name into a strategy

Ask Q about Shinpoong Pharmaceutical, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Shinpoong Pharmaceutical notifications

Quantus Signal · live data · not investment advice · Privacy Policy